159 related articles for article (PubMed ID: 37889062)
1. p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.
Nasir A; Ahmed MK; Saller JJ; Henderson-Jackson EB; Malafa MP; Yeatman TJ; Coppola D
Cancer Genomics Proteomics; 2023; 20(6):522-530. PubMed ID: 37889062
[TBL] [Abstract][Full Text] [Related]
2. Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas.
Henderson-Jackson EB; Helm J; Strosberg J; Nasir NA; Yeatman TJ; Kvols LK; Coppola D; Nasir A
Anticancer Res; 2011 Sep; 31(9):2957-62. PubMed ID: 21868544
[TBL] [Abstract][Full Text] [Related]
3. RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms.
Nasir A; Helm J; Turner L; Chen DT; Strosberg J; Hafez N; Henderson-Jackson EB; Hodul P; Bui MM; Nasir NA; Hakam A; Malafa MP; Yeatman TJ; Coppola D; Kvols LK
Pancreas; 2011 May; 40(4):627-33. PubMed ID: 21499216
[TBL] [Abstract][Full Text] [Related]
4. Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer.
Watanabe G; Ishida T; Furuta A; Takahashi S; Watanabe M; Nakata H; Kato S; Ishioka C; Ohuchi N
Am J Surg Pathol; 2015 Aug; 39(8):1026-34. PubMed ID: 26171916
[TBL] [Abstract][Full Text] [Related]
5. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
[TBL] [Abstract][Full Text] [Related]
6. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
7. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract][Full Text] [Related]
8. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Skirnisdottir I; Seidal T
Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
11. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb.
Nita ME; Nagawa H; Tominaga O; Tsuno N; Hatano K; Kitayama J; Tsuruo T; Domene CE; Muto T
Ann Surg Oncol; 1999; 6(5):481-8. PubMed ID: 10458687
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
15. [Alterations of cell cycle regulating proteins: Rb, p21 and p16 in laryngeal cancer].
Pietruszewska W; Durko M; Kobos J
Otolaryngol Pol; 2007; 61(6):951-7. PubMed ID: 18546941
[TBL] [Abstract][Full Text] [Related]
16. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.
Canavese G; Azzoni C; Pizzi S; Corleto VD; Pasquali C; Davoli C; Crafa P; Delle Fave G; Bordi C
Hum Pathol; 2001 Oct; 32(10):1094-101. PubMed ID: 11679944
[TBL] [Abstract][Full Text] [Related]
17. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.
Zhang MF; Zhang ZY; Fu J; Yang YF; Yun JP
J Transl Med; 2009 Dec; 7():110. PubMed ID: 20025780
[TBL] [Abstract][Full Text] [Related]
18. FGD4 (Frabin) Overexpression in Pancreatic Neuroendocrine Neoplasms.
Shahid M; George TB; Saller J; Haija M; Sayegh Z; Boulware D; Strosberg J; Chakrabarti R; Coppola D
Pancreas; 2019; 48(10):1307-1311. PubMed ID: 31688594
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
Ali A; Serra S; Asa SL; Chetty R
Am J Surg Pathol; 2006 Dec; 30(12):1588-94. PubMed ID: 17122516
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors.
Couvelard A; Deschamps L; Ravaud P; Baron G; Sauvanet A; Hentic O; Colnot N; Paradis V; Belghiti J; Bedossa P; Ruszniewski P
Mod Pathol; 2009 Feb; 22(2):273-81. PubMed ID: 18997736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
